CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C27104 | BRD-K77601667 | BRD-K77601667 | -- | -- | -- | Details |
| C27105 | BRD-K77603027 | BRD-K77603027 | -- | -- | -- | Details |
| C27106 | BRD-K77608452 | BRD-K77608452 | -- | -- | -- | Details |
| C27107 | BRD-K77608736 | BRD-K77608736 | -- | -- | -- | Details |
| C27108 | BRD-K77609086 | BRD-K77609086 | -- | -- | -- | Details |
| C27109 | BRD-K77620628 | BRD-K77620628 | -- | -- | -- | Details |
| C27110 | BRD-K77621546 | BRD-K77621546 | -- | -- | -- | Details |
| C27111 | BRD-K77624847 | BRD-K77624847 | -- | -- | -- | Details |
| C27112 | BRD-K77625572 | etomoxir | CPT1A | Carnitine palmitoyltransferase inhibitor | -- | Details |
| C27113 | BRD-K77625799 | vandetanib | EGFR; FLT1; FLT4; KDR; PTK6; RET; TEK | EGFR inhibitor; VEGFR inhibitor; RET tyrosine kinase inhibitor | -- | Details |
| C27114 | BRD-K77627880 | A-205804 | -- | -- | -- | Details |
| C27115 | BRD-K77627909 | BRD-K77627909 | -- | -- | -- | Details |
| C27116 | BRD-K77629773 | BRD-K77629773 | -- | -- | -- | Details |
| C27117 | BRD-K77631079 | BRD-K77631079 | -- | -- | -- | Details |
| C27118 | BRD-K77634326 | BRD-K77634326 | -- | -- | -- | Details |
| C27119 | BRD-K77634878 | BRD-K77634878 | -- | -- | -- | Details |
| C27120 | BRD-K77634909 | AEG-3482 | -- | -- | -- | Details |
| C27121 | BRD-K77637365 | BRD-K77637365 | -- | -- | -- | Details |
| C27122 | BRD-K77638937 | BRD-K77638937 | -- | -- | -- | Details |
| C27123 | BRD-K77640397 | BRD-K77640397 | -- | -- | -- | Details |
| C27124 | BRD-K77641333 | naphazoline | -- | -- | -- | Details |
| C27125 | BRD-K77643021 | BRD-K77643021 | -- | -- | -- | Details |
| C27126 | BRD-K77644833 | BRD-K77644833 | -- | -- | -- | Details |
| C27127 | BRD-K77644960 | BRD-K77644960 | -- | -- | -- | Details |
| C27128 | BRD-K77658626 | BRD-K77658626 | -- | -- | -- | Details |
| C27129 | BRD-K77660367 | BRD-K77660367 | -- | -- | -- | Details |
| C27130 | BRD-K77663497 | BRD-K77663497 | -- | -- | -- | Details |
| C27131 | BRD-K77663706 | BRD-K77663706 | -- | -- | -- | Details |
| C27132 | BRD-K77677632 | SB-200646 | HTR2B; HTR2C | Serotonin receptor antagonist | -- | Details |
| C27133 | BRD-K77681376 | BRD-K77681376 | -- | -- | -- | Details |
| C27134 | BRD-K77685957 | dequalinium | -- | -- | -- | Details |
| C27135 | BRD-K77687238 | BRD-K77687238 | -- | -- | -- | Details |
| C27136 | BRD-K77690805 | BRD-K77690805 | PKM | Pyruvate kinase isozyme activator | -- | Details |
| C27137 | BRD-K77695569 | tiabendazole | -- | -- | -- | Details |
| C27138 | BRD-K77697725 | BRD-K77697725 | -- | -- | -- | Details |
| C27139 | BRD-K77697841 | BRD-K77697841 | -- | -- | -- | Details |
| C27140 | BRD-K77700305 | BRD-K77700305 | -- | -- | -- | Details |
| C27141 | BRD-K77703574 | BRD-K77703574 | -- | -- | -- | Details |
| C27142 | BRD-K77705921 | BRD-K77705921 | -- | -- | -- | Details |
| C27143 | BRD-K77706833 | BRD-K77706833 | -- | -- | -- | Details |
| C27144 | BRD-K77709215 | BRD-K77709215 | -- | -- | -- | Details |
| C27145 | BRD-K77713205 | BRD-K77713205 | -- | -- | -- | Details |
| C27146 | BRD-K77718491 | BRD-K77718491 | -- | -- | -- | Details |
| C27147 | BRD-K77719922 | BRD-K77719922 | -- | -- | -- | Details |
| C27148 | BRD-K77726270 | BRD-K77726270 | -- | -- | -- | Details |
| C27149 | BRD-K77727343 | BRD-K77727343 | -- | -- | -- | Details |
| C27150 | BRD-K77729938 | BRD-K77729938 | -- | -- | -- | Details |
| C27151 | BRD-K77733130 | BRD-K77733130 | -- | -- | -- | Details |
| C27152 | BRD-K77741497 | BRD-K77741497 | -- | -- | -- | Details |
| C27153 | BRD-K77743611 | BRD-K77743611 | -- | -- | -- | Details |
| C27154 | BRD-K77750380 | BRD-K77750380 | -- | -- | -- | Details |
| C27155 | BRD-K77751431 | BRD-K77751431 | -- | -- | -- | Details |
| C27156 | BRD-K77758624 | BRD-K77758624 | -- | -- | -- | Details |
| C27157 | BRD-K77760488 | BRD-K77760488 | -- | -- | -- | Details |
| C27158 | BRD-K77762110 | BRD-K77762110 | -- | -- | -- | Details |
| C27159 | BRD-K77771411 | moxonidine | NISCH | Imidazoline receptor agonist | -- | Details |
| C27160 | BRD-K77774562 | BRD-K77774562 | -- | -- | -- | Details |
| C27161 | BRD-K77775127 | BRD-K77775127 | -- | -- | -- | Details |
| C27162 | BRD-K77782946 | BRD-K77782946 | -- | -- | -- | Details |
| C27163 | BRD-K77786391 | BRD-K77786391 | -- | -- | -- | Details |
| C27164 | BRD-K77787814 | BRD-K77787814 | -- | -- | -- | Details |
| C27165 | BRD-K77789137 | BRD-K77789137 | -- | -- | -- | Details |
| C27166 | BRD-K77790153 | BRD-K77790153 | -- | -- | -- | Details |
| C27167 | BRD-K77791851 | BRD-K77791851 | -- | -- | -- | Details |
| C27168 | BRD-K77793090 | BRD-K77793090 | -- | -- | -- | Details |
| C27169 | BRD-K77793136 | hydroxyfasudil | ROCK1 | Rho associated kinase inhibitor | -- | Details |
| C27170 | BRD-K77795481 | BRD-K77795481 | -- | -- | -- | Details |
| C27171 | BRD-K77797589 | BRD-K77797589 | -- | -- | -- | Details |
| C27172 | BRD-K77797840 | BRD-K77797840 | -- | -- | -- | Details |
| C27173 | BRD-K77800502 | BRD-K77800502 | -- | -- | -- | Details |
| C27174 | BRD-K77801455 | BRD-K77801455 | -- | -- | Propionylamino-acetic acid 2-oxo-2-phenyl-ethyl ester | Details |
| C27175 | BRD-K77804886 | BRD-K77804886 | -- | -- | -- | Details |
| C27176 | BRD-K77805051 | BRD-K77805051 | -- | -- | -- | Details |
| C27177 | BRD-K77808555 | BRD-K77808555 | -- | -- | -- | Details |
| C27178 | BRD-K77811363 | BRD-K77811363 | -- | -- | -- | Details |
| C27179 | BRD-K77814566 | BRD-K77814566 | -- | -- | -- | Details |
| C27180 | BRD-K77817104 | BRD-K77817104 | -- | -- | -- | Details |
| C27181 | BRD-K77820593 | BRD-K77820593 | -- | -- | -- | Details |
| C27182 | BRD-K77820762 | BRD-K77820762 | -- | -- | -- | Details |
| C27183 | BRD-K77824583 | BRD-K77824583 | -- | -- | -- | Details |
| C27184 | BRD-K77827548 | BRD-K77827548 | -- | -- | -- | Details |
| C27185 | BRD-K77830450 | forskolin | ADCY2 | Adenylyl cyclase activator | -- | Details |
| C27186 | BRD-K77831863 | BRD-K77831863 | -- | -- | -- | Details |
| C27187 | BRD-K77832645 | BRD-K77832645 | -- | -- | -- | Details |
| C27188 | BRD-K77834935 | BRD-K77834935 | -- | -- | -- | Details |
| C27189 | BRD-K77835518 | BRD-K77835518 | -- | -- | -- | Details |
| C27190 | BRD-K77836949 | BRD-K77836949 | -- | -- | -- | Details |
| C27191 | BRD-K77841042 | brefeldin-a | -- | -- | -- | Details |
| C27192 | BRD-K77845452 | BRD-K77845452 | -- | -- | -- | Details |
| C27193 | BRD-K77845911 | BRD-K77845911 | -- | -- | -- | Details |
| C27194 | BRD-K77856555 | KU-C103874 | -- | -- | -- | Details |
| C27195 | BRD-K77869064 | BRD-K77869064 | -- | -- | -- | Details |
| C27196 | BRD-K77869482 | BRD-K77869482 | -- | -- | -- | Details |
| C27197 | BRD-K77871059 | BRD-K77871059 | -- | -- | -- | Details |
| C27198 | BRD-K77873562 | BRD-K77873562 | -- | -- | -- | Details |
| C27199 | BRD-K77874118 | BRD-K77874118 | -- | -- | -- | Details |
| C27200 | BRD-K77875023 | BRD-K77875023 | -- | -- | -- | Details |
| C27201 | BRD-K77876724 | YL-51 | -- | -- | -- | Details |
| C27202 | BRD-K77877235 | BRD-K77877235 | -- | -- | -- | Details |
| C27203 | BRD-K77877933 | I-606061 | -- | -- | -- | Details |